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Abstract Neurological and neuropsychiatric diseases ac-
count for considerable healthcare, economic and social bur-
dens in Ghana. In order to effectively address these burdens,
appropriately-trained scientists who conduct high-impact neu-
roscience research will be needed. Additionally, research di-
rections should be aligned with national research priorities.
However, to provide information about current neuroscience
research productivity and direction, the existing capacity and
focus need to be identified. This would allow opportunities for
collaborative research and training to be properly explored
and developmental interventions to be better targeted. In this
study, we sought to evaluate the existing capacity and direc-
tion of neuroscience-related research in Ghana. To do this, we
examined publications reporting research investigations
authored by scientists affiliated with Ghanaian institutions in
specific areas of neuroscience over the last two decades
(1995–2015). 127 articles that met our inclusion criteria were
systematically evaluated in terms of research foci, annual pub-
lication trends and author affiliations. The most actively-
researched areas identified include neurocognitive
impairments in non-nervous system disorders, depression
and suicide, epilepsy and seizures, neurological impact of
substance misuse, and neurological disorders. These studies
were mostly hospital and community-based surveys. About
60 % of these articles were published in the last seven years,
suggesting a recent increase in research productivity.
However, data on experimental and clinical research outcomes
were particularly lacking. We suggest that future investigations
should focus on the following specific areas where information
was lacking: large-scale disease epidemiology, effectiveness of
diagnostic platforms and therapeutic treatments, and the genet-
ic, genomic and molecular bases of diseases.
Keywords Mental health . Neuroscience . Research
capacity . Science policy . Research focus . Ghana
Introduction
The negative impacts of neurological and neuropsychiatric
diseases on healthcare, economic and social systems have
been widely reported (Dua et al. 2006; George-Carey et al.
2012; Murray and Lopez 1996; Olayinka and Mbuyi 2014;
Quansah and Karikari 2015). A notable example is the 1996
Global Burden of Disease report, which showed that neuro-
psychiatric diseases accounted for more than a quarter of all
health losses due to disability (Murray and Lopez 1996).
Health loss resulting from neuropsychiatric diseases was also
estimated to be twenty-fold greater than the burden of cancer,
and over eight times greater than that of coronary heart disease
(Murray and Lopez 1996). In Africa, dementia has been esti-
mated to affect 2.4 % of all adults aged fifty years and above;
this translated to 2.76 million people suffering from dementia
as of the year 2010 (George-Carey et al. 2012). The available
data also shows that an appreciable number of Africans suffer
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from neurological diseases, including Alzheimer’s disease,
Parkinson’s disease (PD) and motor neuron diseases
(Blanckenberg et al. 2013; Lekoubou et al. 2014; Quansah
and Karikari 2015). These diseases represent high burdens
on the continent’s economic, social and healthcare systems
(Blanckenberg et al. 2013; Cilia et al. 2011; George-Carey
et al. 2012). As the prevalence of neurological and neuropsy-
chiatric diseases in Africa has been predicted to increase in the
near future, the amount of disease-associated burdens are also
expected to rise (George-Carey et al. 2012). Furthermore,
many common diseases in Africa do have associated
neurocognitive impairments; examples include malaria, tuber-
culosis, Human Immunodeficiency Virus/ Acquired Immune
Deficiency Syndrome (HIV/AIDS) and the neglected tropical
diseases (Alkali et al. 2013; Karuppiah et al. 2009; Lekoubou
et al. 2014; Mireku et al. 2015; Pepper et al. 2009). Taken
together, neurological and neuropsychiatric diseases, as well
as neurocognitive problems associated with non-nervous sys-
tem disorders, do represent major public health challenges in
Africa. For this reason, improved funding and policy support
from the continent’s political, economic, healthcare and scien-
tific community towards the better understanding of disease
epidemiology, aetiology and propagation is needed in order to
help accelerate the development of measures aimed at disease
control and treatment (Abdulmalik et al. 2014; Awenva et al.
2010; Lekoubou et al. 2014). Improved investment in neuro-
science research in Africa would not only benefit the continent
in terms of providing further molecular, genetic and clinical
insights into neurological and neuropsychiatric diseases, but
would also help to better address neurocognitive impairments
associated with common non-nervous system disorders
(Karikari et al. 2015a; Karikari and Aleksic 2015).
Recent studies have shown that the genetic basis of some
neurological diseases (including PD, spinal muscular atrophy
and amyotrophic lateral sclerosis) differ between African and
non-African populations (Blanckenberg et al. 2013; Karikari
and Aleksic 2015; Quansah and Karikari 2015). However,
knowledge gaps exist regarding how these diseases progress
among African populations, and also concerning the molecu-
lar basis of disease susceptibility and resistance among specif-
ic populations and individuals (Karikari and Aleksic 2015;
Quansah and Karikari 2015). In order to address these knowl-
edge gaps, more innovative approaches must be developed.
One of the fundamental approaches might be to identify poten-
tially more effective methods of assessing disease epidemiolo-
gy (Mutabaruka et al. 2011). This would inform policymakers,
health planners, scientists and the general public about the sig-
nificance of the problem, potentially leading to the develop-
ment of more capacity-building and cross-sector collaborative
efforts to address the issues (Mutabaruka et al. 2011).
Currently, there is uneven representation of African coun-
tries and specific populations in neurological and neuropsy-
chiatric disease epidemiology reports (Baxter et al. 2013;
Blanckenberg et al. 2013; George-Carey et al. 2012;
Lekoubou et al. 2014; Olayinka and Mbuyi 2014; Quansah
and Karikari 2015). Global disease surveillance systems such
as the United Nations Children’s Fund (UNICEF)’s Multiple
Indicator Cluster Surveys, the United States Agency for
International Development (USAID)-funded Demographic
and Health Surveys project and the World Health
Organization (WHO)’s Stepwise Approach to Chronic
Disease Factor Surveillance have been using dynamic ap-
proaches to quantify the burden of non-communicable dis-
eases in low- and middle-income countries (Bonita 2009;
Corsi et al. 2012; http://mics.unicef.org). Nonetheless,
epidemiology of the wide spectrum of neurological and
neuropsychiatric diseases in Africa have not been fully
reported in these surveys (Lekoubou et al. 2014; Quansah
and Karikari 2015). This lack of epidemiological data may
contribute to the poor patient support systems and the
ineffectiveness of mental health- and dementia-related poli-
cies available in countries (Abdulmalik et al. 2014; Olayinka
and Mbuyi 2014; Sipsma et al. 2013). One could argue that
since the burdens of these diseases have not been adequately
quantified, health planners and policy makers lack the scien-
tific evidence to depend upon to make adequate resource pro-
visions for biomedical research and healthcare (Baxter et al.
2013). This is exemplified by the evidence that many patients
suffering from these diseases in several countries receive no
treatment. The WHO’s World Mental Health survey, for in-
stance, estimated that only 20 % of patients diagnosed with
serious mental health disorders in Nigeria received treatment
in a particular year (Wang et al. 2007). Similar healthcare gaps
have also been reported from other sub-Saharan African
(SSA) countries, including Ghana (Abdulmalik et al. 2014;
Ferri et al. 2004). Most SSA countries have low policy prior-
ities for neurological and neuropsychiatric diseases; research
and healthcare in this area are often hampered by inadequate
human resources, poor funding, as well as widespread public
misconceptions regarding neurological and mental health is-
sues (Gureje et al. 2007; Saraceno et al. 2007). There is usu-
ally a tendency to prioritise programmes targeting infectious
diseases, malaria and reproductive health, leaving the neuro-
sciences and related areas with minimal resources (Prince
et al. 2007). As a result, while most of the global burden
of neurological and neuropsychiatric diseases occurs in
low- and middle-income countries, these countries have
the least resources to address these disorders and their
associated problems (Baxter et al. 2013; World Health
Organization 2010).
Although Ghana is actively involved in biomedical re-
search, neuroscience seems neglected in terms of both
healthcare and research (Doku et al. 2012; World Health
Organization 2010; Sipsma et al. 2013). Data on disease epi-
demiology, treatment options and outcomes, and biomedical
research findings are lacking (Read and Doku 2012). In the
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absence of reliable data, attempts have been made to fill the
gap with information extrapolated from international esti-
mates; however, this approach may not provide a true repre-
sentation of the situation (Read and Doku 2012). In order to
develop neuroscience-related research, clinical and social care
in Ghana, a few interventions have been introduced recently.
These include the enactment of a mental health law by the
Parliament of the Republic of Ghana (Act 846 of 2012), aimed
at introducing a paradigm shift in the delivery of mental health
services in the country, moving from an institution-based ap-
proach to a community-based model (Roberts et al. 2014).
The law was also designed to address the disturbing social
challenges of stigmatisation and discrimination against
mentally-ill individuals (Roberts et al. 2014; World Health
Organization 2011). Although the new law and training initia-
tives such as The Kintampo Project (http://www.
thekintampoproject.org) provide new directions in mental
health development and workforce training, additional
efforts are required to provide more comprehensive in-
country data and resources to address neuroscience-related
issues.
The success of a country’s local research efforts depends
largely on the capacity of the available research workforce
(Kennard 2000; Saraceno et al. 2007). Therefore, for the
existing and future efforts aimed at addressing neurological
diseases and related problems in Ghana to be successful, the
preparedness of resident scientists to help execute these as-
signments needs to be addressed. Here, we aimed to provide
evidence on the capacity of scientists for neuroscience-related
research in Ghana, through a systematic evaluation of the
published literature over the past two decades. By using sci-
entific publications as a measure of research productivity, we
were able to analyse publication trends, research foci, as well
as institutional distribution of scientists working in this area.
The information provided here will serve as a resource to
inform the development of neuroscience education and re-
search in Ghana, by targeting capacity-building efforts and
other support programmes to areas where the need exists.
Methods
Data sources and search strategy
We searched PubMed, MEDLINE via EBSCO, African
Journals Online, ScienceDirect, Google and Google Scholar
for neuroscience-related studies conducted on Ghanaian sub-
jects and those authored by scientists affiliated with Ghanaian
institutions over the last two decades (1st January 1995 to 10th
April 2015). We used the following search terms in combina-
tionwith BGhana^: Bneurological disorders,^ Bmental health,^
Bpsychiatric disorders,^ Bdementia,^ BAlzheimer’s disease,^
BParkinson’s disease,^ Bautism,^ Battention deficit
hyperactivity disorder,^ BBipolar Disorder,^ BObsessive
Compulsive Disorder,^ Bdyskinesia,^ Bdepression,^
Bepilepsy,^ Bconvulsion,^ Bseizure,^ Bpsychological health,^
Bcerebrum,^ Bcerebellum,^ Bcortex^ and Bneuroscience^.
Subsequently, we scanned the references from the articles ob-
tained from the initial search for potential articles we might
have missed. We subsequently evaluated the articles obtained
(titles, abstracts, and then full texts) and screened them for
inclusion (see below for inclusion criteria and Fig. 1 for article
selection flow chart).
Study selection
We selected studies conducted in Ghana that reported on any
aspect of neuroscience; including neurological diseases, men-
tal health and experimental neuroscience. No restrictions were
made with regards to study design but studies not focusing on
Ghana or not including Ghanaian subjects were removed.
Duplicate entries were also removed.
Results and discussion
A total of 359 articles were identified through the literature
search. These articles were evaluated and 127 publications that
met the inclusion criteria were selected for further analyses
(Fig. 1). Initially, the publications were grouped into themes
based on their research foci. The following are the number of
studies per research focus: epilepsy and seizures (9 studies),
depression and suicide (14 studies), neurological disorders (6
studies), neurocognitive impairments in non-nervous system
disorders (20 studies), nervous system effects of substance mis-
use (7 articles), and mental health among women (18 articles).
Others included: the national mental health system (16 studies),
support and help-seeking for mental health patients (6 studies),
psychopharmacology and pharmacogenetics (3 studies), com-
munity studies such as those that investigated the relation be-
tween poverty andmental health (11 articles), as well as clinical
surveys and case reports (13 articles). The percentage distribu-
tion of the number of articles for each research focus is provid-
ed in Table 1. These articles were further evaluated based on the
(i) specific focus of the research reported (ii) number of articles
reported under a particular research area, expressed as a per-
centage of the total number of articles evaluated, and (iii) an-
nual publication trends and the institutional affliliations of
Ghanaian authors (Table 1 and Fig. 2). We identified that about
60 % of the articles evaluated were published within the last
seven years (Fig. 2). In the rest of this article, we will discuss in
detail the epidemiology of neurological and neuropsychiatric
disorders as reported from Ghana, the neuroscience-related re-
search directions in the country, as well as the established legal
and healthcare frameworks regulating neuropsychiatric service
delivery. We will also discuss the existing neuroscience
Metab Brain Dis (2016) 31:11–24 13
research capacity in the country, areas where improvement is
needed and what might be required to deliver this
improvement.
Epidemiology of neurological and neuropsychiatric
diseases
Initial studies, conducted over five decades ago, predicted
future increases in the burden of psychiatric disorders in
Ghana due to anticipated impacts of industrialisation and ac-
culturation (Field 1958). However, it remains largely un-
known whether these predictions have been achieved or not.
This is because recent epidemiological studies have focused
mainly on small sections of the population and have relied
almost exclusively on clinical surveys (Read and Doku
2012). While the review of hospital records provides impor-
tant information about disease epidemiology, hospital cases
alone may not be reliable indicators of disease prevalence,
especially in African settings where (i) many people have
difficulties accessing healthcare (ii) the under-resourced and
over-stretched nature of healthcare facilities means that not all
patients can be adequately attended to (iii) record keeping in
health facilities is sometimes poor, and (iv) appreciable por-
tions of the population depend on herbal and traditional med-
icine for their healthcare needs (Ferri et al. 2004; Nguta et al.
2015; Roberts et al. 2014; van Andel et al. 2012). Larger-scale
and more diverse epidemiological studies combining data
from multiple sources are therefore required. This would help
to inform new decisions in health policy, preventive
healthcare, evidence-based medical practice as well as
better-targeted biomedical research aimed at identifying dis-
ease risk factors and potential therapeutic targets and agents
(Quansah and Karikari 2015).
One of the major studies identified in terms of disease
epidemiology was a retrospective study conducted into the
prevalence of psychiatric disorders among adolescents
attending a psychiatric out-patient clinic in Accra from 1987
to 1994 (Turkson 1996). Out of the 454 adolescents (239
females) whose records were reviewed, 269 patients
(59.3 %) were reportedly diagnosed with psychiatric illnesses.
Out of these 269 patients, 88 were diagnosed with functional
psychoses (including depression and psychoneurotic disor-
ders), 55 were diagnosed with personality disorders, 27 were
diagnosed with organic psychoses and 36 were suffering from
other kinds of psychiatric disorders (Turkson 1996).
A frequently-used means to assess disease occurrence and
people’s perceptions about diseases is self-reported communi-
ty surveys (Hunt and Bhopal 2004). Community-based stud-
ies reporting on the prevalence of psychiatric disorders and
related diseases have been conducted in Ghana, although the
use of standardised epidemiological methods have been lack-
ing in some of these investigations (Ferri et al. 2004; Field
1958). By using a self-reported questionnaire and mental state
examinations, Osei (2003) interviewed 194 study participants
in Kumasi, the capital of the Ashanti region. It was identified
that five women who participated in the study were suffering
from schizophrenia, five men were suffering from
somatisation and 38 others (including 33 women) were living
with depressive illness. A psychiatric illness prevalence rate of
27.51 % was reported from this study. More of such
community-based surveys conducted on larger scales are ur-
gently needed to help in the estimation of disease prevalence.
This is particularly necessary due to the fact that many
Ghanaians seek healing from neurological and psychiatric
conditions from spiritual centres, meaning that such people
would be missed in clinical record surveys (Turkson 2000).
The focus of research on neurological
and neuropsychiatric diseases in Ghana
Research on neurological diseases in Ghana is limited. The
available studies in this area reported on PD (three studies),
127 articles analysed
359 articles 
Identified from PubMed, MEDLINE, African Journals Online, Google Scholar, 
Science Direct and Google
232 articles excluded
● 122 not focused on Ghana 
● 72 duplicates
● 21 focused on non-neuroscience-
related diseases 
● 8 focused on sub-Saharan African 
countries excluding Ghana 
● 9 published outside of 1995 - 2015
Fig. 1 Flow diagram showing
the article selection process
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economic impacts of dementia and a clinical report on a
schizophrenic patient (one study each). Only one study fo-
cused on the genetic aspect of a disease. In that study, 54
patients suffering from PD and 46 matched controls were
screened for the presence of the G2019S pathogenic mutation
in the leucine-rich repeat kinase 2 (LRRK2) gene, which has
been associated with familial PD (Cilia et al. 2012). However,
this mutation was not found in the genome of both the patients
and controls, suggesting that the genetic basis of familial PD
among Ghanaians might differ from people elsewhere (Cilia
et al. 2012). This finding corroborated earlier reports from
Nigeria and South Africa that showed that the LRRK2-
G2019S pathogenic mutation was missing among study sub-
jects (Bardien et al. 2010; Okubadejo et al. 2008). These re-
sults support the growing body of evidence suggesting that the
genetic basis of specific neurological diseases is population-
specific, justifying the need for further studies into how
these diseases progress among African populations
(Karikari and Aleksic 2015; Quansah and Karikari
2015). Given that modern humans were believed to
have originated from Africa, increasing the involvement
of African populations in disease-focused genetic and
genomic studies might provide novel information that
would shape the future of neurological research and
healthcare on the continent (Karikari and Aleksic 2015).
Another disease that has received research attention in
Ghana is epilepsy. In 1995, it was reported that convulsive
disorder accounted for 3 % of outpatient visits to the pediatric
department of Ghana’s biggest tertiary hospital, Korle Bu
teaching hospital, over a decade (Commey 1995). 51.5 % of
these patients were enrolled in the hospital’s pediatric
neurodevelopmental clinic (Commey 1995). In examining da-
ta on active convulsive epilepsy from five African countries
including Ghana, Kariuki et al. (2014) identified some impor-
tant features (seizure types, neurologic deficits, encephalopa-
thy) and co-morbidities (malnutrition, cognitive impairment).
Based on the findings, it was proposed that these features
should be integrated into the management of epilepsy. Even
though epilepsy is one of the most-studied neuropsychiatric
disorders in Ghana, the available investigations were mostly
clinical reports; non-hospital-based estimations of disease
prevalence, potential causes and public perceptions about the
disease were lacking. One of the largest community surveys
on epilepsy was conducted by Nyame and Biritwum (1997).
Upon interviewing 380 participants in Accra, the researchers
reported that while almost all the people sampled could accu-
rately describe an epileptic person, 172 (45.3 %) of them did
not know the cause of epilepsy and 37.6 % did not know how
it could be treated (Nyame and Biritwum 1997). It was further
reported that out of the 358 responses about the causes of
epilepsy, 114 (31.8 %) respondents believed that epilepsy






























































































































































































































































































































































































































































































































































































































18 Metab Brain Dis (2016) 31:11–24
Furthermore, efforts have been directed at estimating the
prevalence of depression among Ghanaians, particularly
among women. In a cross-sectional analysis using data from
a national representative survey conducted in 2009–2010 (in-
volving 9,524 participants), the Kessler Psychological
Distress scale was used to measure psychological distress
(Sipsma et al. 2013). An overall psychological distress rate
of 18.7 % was reported among the participants, with 11.7
and 7.0 % reporting either moderate or severe psychological
distress respectively. Moreover, it has recently been reported
that out of 270 university students (138 females) interviewed
using the Center for Epidemiological Studies Short
Depression Scale (CES-D10), overall prevalence of depres-
sion among university students in Ghana was estimated to
be 39.2 %, with 31.1 and 8.1 % having either mild or severe
depressive symptoms respectively (Oppong Asante and
Andoh-Arthur 2015). Given the cross-sectional nature of most
of these studies, increased numbers of participants may be
required in order to make future findings more representative.
Substance misuse is another area that has been given re-
search attention. Studies here have been focused principally
on the neuropsychiatric effects of tobacco and alcohol use.
With regard to this, Yawson et al. (2013) estimated the prev-
alence of daily tobacco smoking among adults in Ghana to be
7.6 %. This data was generated from 4305 study subjects aged
50 years and above.
Other publications were focused on mental health among
women. These studies reported specifically on antenatal de-
pression, antepartum depression, anxiety disorders and de-
pression among infertile women (Table 1). In addition, a
few other publications reported on the following: the
relation between poverty and mental health, psychophar-
macology, the use of herbal medicine in treating neuro-
psychiatric conditions, and help-seeking and support
system for patients (Table 1).
Overall, it is worth noting that no research work has been
conducted on diseases such as Alzheimer’s disease, fronto-
temporal dementia, bipolar disorders, Huntington’s disease,
dyskinesia as well as neurodevelopmental disorders such as
autism and attention deficit hyperactivity disorder. Hence, the
prevalence, causes (both genetic and sporadic) and patient
care platforms for these disorders in Ghana have not been
evaluated. Moreover, reports on the genetic, genomic and mo-
lecular underpinnings of common neurological diseases and
neurological aspects of other diseases were lacking. A plausi-
ble explanation would be that the scientific capacity for ex-
perimental neuroscience and neurology research in Ghana is
low (Karikari and Quansah 2015). This viewpoint is support-
ed by findings of the Thomson Reuter’s Global Research
Report in 2010. While Ghana was the sixth best-ranked coun-
try in central Africa in terms of annual number of publications
(in this report, African countries were broadly categorised into
north, south and central Africa), the country was not part of
the top five African countries in the neuroscience and behav-
iour field (Adams et al. 2010).
Appropriate mechanisms should therefore be developed to
improve neuroscience research (particularly bench-science,
clinical and computational aspects) in the country (Karikari
and Quansah 2015).
Publication trends and institutions conducting
neuroscience-related research in Ghana
The average number of publications on neuroscience-related
research from Ghana between 1995 and 2008 was about six
per year. However, a change in this trendwas later observed as
over 60% of the articles were published in the last seven years
(2009–2015), with about 20 articles published in 2013 alone
(Fig. 2). This represents a recent improvement in
neuroscience-related research output in Ghana. Most of the
studies were either clinical case reports or community-based
studies, with only a few (4.7 %; Table 1) examining neurolog-
ical and neurodegenerative disorders. In addition, about
15.7% (Table 1) of the studies investigated the neurocognitive
impairments associated with non-nervous system diseases,
giving an indication that scientists in Ghana have been apply-
ing neuroscience concepts to address pressing health concerns
in diseases such as HIV/AIDS, breast cancer and malaria.
With most of the publications being hospital-based reviews,
majority of the authors were affiliated with the two leading
hospitals in Ghana, that is, the Korle-Bu teaching hospital
(KBTH) and the Komfo Anokye teaching hospital (KATH;
















20Fig. 2 Annual distribution of
neuroscience-related publications
authored by scientists affiliated
with Ghanaian institutions over
the last two decades (1995–2015)
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Table 1). Many other authors were affliliated with the
University of GhanaMedical School, which is associated with
KBTH. The remaining authors were affiliated with universi-
ties such as the Kwame Nkrumah University of Science and
Technology, the University of Development Studies, the
University of Cape Coast and the University of Education
(Table 1). The Kintampo Health Research Center and
Noguchi Memorial Institute for Medical Research were also
identified as the major research centers contributing to
neuroscience-related research in Ghana (Table 1).
Ghana’s mental health system and the mental health law
There are currently three psychiatric hospitals in Ghana; these
are the Accra, Pantang and Ankaful psychiatric hospitals
(Roberts et al. 2014). These hospitals have a total of about
1322 beds, although only one has a children’s ward consisting
of 15 beds (Roberts et al. 2014). In 2011, in-patient admis-
sions in the three hospitals totalled 7993; 32 % of these pa-
tients were females while 68 % were males (Roberts et al.
2014). The major diagnoses leading to in-patient admissions
included schizophrenia (32 %), substance misuse (26 %),
mood disorders (19 %), and neurotic/stress-related disorders
(1 %) (Roberts et al. 2014). Disorders such as epilepsy
accounted for 6 % of all in-patient admissions. The combined
human resource capacity of these hospitals is 1887, including
8 psychiatrists (Roberts et al. 2014). This brings the
psychiatrist- to- population ratio to 0.07 per 100,000 persons.
There are also 31 non-psychiatrist medical doctors, 21 social
workers, 4 occupational therapists, 19 psychologists, 1,256
nurses and 546 other workers (including health assistants
and other auxilliary staff) (Roberts et al. 2014). These data
suggest that the psychologist- to- population ratio in Ghana
is 0.08:100,000 and the psychiatric nurse- to- population ratio
is 5.19:100,000 (Roberts et al. 2014). With regards to treat-
ment, only 19 % of patients in the psychiatric hospitals are
reported to receive one or more psychosocial interventions,
and all the hospitals had at least one psychotropic drug in each
therapeutic class (antidepressant, anti-psychotic, mood
stabiliser, antiepileptic and anxiolytic drugs) available in their
facilities throughout the year (Roberts et al. 2014). However,
the hospitals sometimes run out of drugs such as olazipine (an
antipsychotic medication), compelling patients to be put on
other drugs (Roberts et al. 2014).
The foregoing overview of Ghana’s mental health delivery
system shows that there is an urgent need to train more
healthcare professionals to support efficient psychiatric care
delivery. The low availability of pharmaceutical supplies is
also an important concern that needs to be addressed. At the
end of the year 2011, the total government spending onmental
health delivery was about 1.4 % of the total national health
budget (Roberts et al. 2014;World Health Organization 2011).
Figures from the Ministry of Health indicate that the mental
health sector was allocated a budget of 4,516,163 Ghana cedis
(excluding staff salaries) (Roberts et al. 2014). However, a
total amont of 5,656,974 Ghana cedis was spent on the deliv-
ery of mental health services, showing that the initially-
approved funding was less than what was actually needed
(Roberts et al. 2014). Most of this amount was spent on oper-
ational expenses at the psychiatric hospitals, meaning that
costs incurred in the delivery of psychiatric care in other
health facilities were not considered here (Roberts et al.
2014; World Health Organization 2011). Also, no mental dis-
order is covered by social insurance schemes and there are no
social benefits for patients, leaving the financial burden solely
to patients, families and carers (World Health Organization
2011). In addition to public funding, some international de-
velopment partners and non-profit organisations have contrib-
uted to mental health delivery in Ghana. The contributions of
these agencies have usually been made through the donation
of essential drugs (Roberts et al. 2014).
In March 2012, the Parliament of Ghana successfully
passed the Mental Health Act into law (Act 846 of 2012)
(Doku et al. 2012). The aim was to increase the quality of
mental healthcare through improved protection of the rights
of patients and clinicians (Doku et al. 2012). However,
three years after the passage of this law, there are still chal-
lenges and weaknesses in the implementation of policy and
legislative frameworks. Among these challenges are (i) insuf-
ficient government funding towards the efficient delivery of
mental health services (ii) little use of the legal provisions to
effectively regulate the detention and handling of patients in
health facilities and spiritual healing centres (iii) lack of regu-
lation regarding the practice of psychiatry by traditional and
spiritual healers, and (iv) insufficient use of clinical guidelines
even where they exist (Doku et al. 2012; Roberts et al. 2014).
Moreover, several challenges also exist in terms of mental
health service delivery, recordkeeping and records monitoring
and evaluation (Roberts et al. 2014; World Health
Organization 2011). Mental health information systems are
not regularly updated. Similarly, mental health data are not
consistently aggregated to provide national reports on the bur-
den of mental health (Roberts et al. 2014).
The mental health policy was formulated and implemented
by the Ministry of Health and the Ghana Health Service re-
spectively (World Health Organization 2011). The existing
mental health policy was revised in 1996 and refined in
2012 but it still does not address the integration of mental
health into primary health care (World Health Organization
2011). However, the policy includes the following compo-
nents: protection of human rights of patients, human re-
sources, involvement of users and families, advocacy and pro-
motion, equity of access to mental health services across dif-
ferent groups, financing, monitoring system, quality improve-
ment and a list of essential medicines (including anxiolytics,
antipsychotics, antidepressants, antiepileptic drugs and mood
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stabilisers) (Roberts et al. 2014; World Health Organization
2011). The so-called 2007–2011 Mental Health Strategy en-
sured the revision of the mental health plan and contained a
budget, specific goals and timeframes (Roberts et al. 2014).
However, due to lack of funds many of the goals have been
unattained. Additionally, the country has no emergency or di-
saster preparedness plan for mental health (Roberts et al. 2014).
Neuroscience research capacity: challenges and prospects
The foregoing discussion is a clear indication that, while ma-
jor achievements have been recorded, research in neurosci-
ence in Ghana needs to improve both in diversity and quantity.
Particularly, information is lacking on the (i) epidemiology of
many mental and neurological disorders (ii) effectiveness of
psychotropic treatments (iii) genetic, genomic and molecular
bases of neurological and neuropsychiatric disorders (iv) so-
cial, economic and healthcare implications of these diseases,
and (v) effectiveness of therapeutic approaches and patient
care platforms currently used. In this section, we will highlight
some of the challenges that have contributed to the low neu-
roscience capacity in Ghana. We will also provide some sug-
gestions and discuss current approaches aimed towards build-
ing capacity for neuroscience research in Ghana.
Inadequate expert scientists
Neuroscience is a rapidly evolving field, with implications for
social development and economic growth through its applica-
tions in areas such as education, business management, soci-
ology, economics, criminal justice, psychology and advertis-
ing (Karikari et al. 2015a; Yusuf et al. 2014). Investment in
neuroscience education and research is therefore likely to make
enormous contributions to building better societies through im-
proved understanding of how the brain works and the applica-
tion of this knowledge to improve service delivery (Karikari
et al. 2015a; Yusuf et al. 2014). However, neuroscience attracts
relatively low interests from Ghanaian students and scientists,
leading to a disparity in research output between Ghana and
other countries (Karikari et al. 2015a, b). This apparent lack of
interest is mostly due to challenges such as the lack of research
funding, inadequate research infrastructure as well as the lack
of degree programmes to prepare students for careers in neuro-
science (Karikari et al. 2015a, b). Difficulties in accessing well-
resourced neuroscience research facilities in the country may
also contribute to the low availability of molecular and genetic
studies into neurological and neuropsychiatric diseases.
Additionally, the dearth of resident neuroscientists plays a ma-
jor role in the absence of neuroscience degree programmes in
the country, due to the unavailability of experts required to
provide world-class student training in this area (Karikari
et al. 2015a, b). In order to attract more researchers and students
into neuroscience in Ghana, the development of strategies
aimed at addressing the infrastructural, training and funding
issues will be essential (Karikari 2015a; Karikari et al.
2015a). Ongoing and suggested attempts to address these chal-
lenges have been discussed in the sections below.
Neuroscience research infrastructure and training
programmes
Although there are dozens of registered higher education in-
stitutions in Ghana, there is no degree programme in neuro-
science offered in the country at the moment (Karikari et al.
2015a, b; Karikari and Quansah 2015). This negatively affects
the supply of scientists and clinicians with appropriate training
in neuroscience to help improve biomedical research and
healthcare delivery in the country (Karikari et al. 2015a;
Karikari and Aleksic 2015). In order to provide well-
resourced facilities for neuroscience research in Ghana, the
KBTH in partnership with the Korle Bu Neuroscience
Foundation (KBNF; a registered charity dedicated to
supporting neurological healthcare, education and research)
are working towards the establishment of a proposed Korle
Bu Neuroscience Center of Excellence (KBNCE) (Cain
2011). Under KBNCE, a collaborative neuroscience graduate
programme has been proposed to provide local opportunities
for Ghanaian students to study neuroscience (Cain 2011). This
programme, which would be offered at the University of
Ghana, is aimed at supporting the future sustainability of the
research component of the KBNCE through the development
of basic and clinical neuroscience research capacity in the
country (Cain 2011). The introduction of interdisciplinary
graduate programmes of this nature would greatly benefit
the country, by enhancing collaborative research especially
those requiring neuroscience expertise (Karikari et al. 2015a,
b). Due to the challenging nature of neuroscience education,
particularly in resource-limited environments, institutional
partnerships between neuroscience and computer science de-
partments would support student training in the use of
Internet- and computer-based tools in exploring neuroscience
concepts and techniques (Karikari 2015b, c). Aside from de-
gree programmes, practising scientists and clinicians wanting
to deepen their neuroscience knowledge in order to advance
their research and teaching activities may find the short-term
training programmes offered for African scientists useful.
Notable examples of these programmes include the fol-
lowing: (i) training programmes in neurogenetics, insect
neuroscience, genomics data analysis and open labware
provided by the science-based non-profit Teaching and
Research in Natural Sciences for Development in Africa
(TReND; http://trendinafrica.org) (ii) other neuroscience-
focused workshops organised under the sponsorship of
the International Brain Research Organization (IBRO)
and other organisations to provide practical training in
specific neuroscience research areas to African
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scientists, and (iii) IBRO-funded teaching tools work-
shops aimed at training faculty members in the best
methodology for the effective teaching of neuroscience
in Africa (Baden et al. 2015; Juliano 2012; Karikari
2015a; Karikari et al. 2015a; Karikari and Aleksic
2015; Yusuf et al. 2014).
The ability of scientists to undertake high-impact research
in neuroscience in Ghana is often hindered by the low avail-
ability of appropriate technology, modern equipment and local
content in the scientific literature (Awenva et al. 2010;
Karikari et al. 2015a). Addressing these challenges would
contribute immensely to bridging the existing scientific pro-
ductivity gap between Ghana and other countries (Awenva
et al. 2010). Higher education institutions in Ghana could
benefit from training and research equipment donation
programmes offered by organisations such as Seeding Labs
( h t t p : / / s e e d i n g l a b s . o r g ) , Ad equ a t i o n ( h t t p : / /
a d equa t i onge rmany. emb l . d e / ) , TReND (www.
TReNDinAfrica.org) and KBNF (http://kbnf.org/). These
organisations support African hospitals, research centres and
universities with functional medical and research equipment.
Details about how these initiatives work have been provided
elsewhere (Karikari et al. 2015a; Yusuf et al. 2014).
Ghanaian scientists could also benefit from travel fel-
lowships and short courses offered or supported by in-
ternational organisations such as IBRO, the Society for
Neuroscience (SfN), the National Academy of Sciences
(USA), the United Nations Educational, Scientific, and
Cultural Organization (UNESCO), Guarantors of Brain
and The World Academy of Sciences to help scientists
in developing countries to obtain state-of-the-art neuro-
science training. Some of these workshops have been
aimed at building scientific capacity in Ghanaian univer-
sities, helping to improve teaching and learning of neu-
roscience. For example, IBRO’s fourth teaching tools
workshop, funded by IBRO with support from
UNESCO, SfN and NAS was held at the University of
Cape Coast Medical School in Cape Coast, Ghana, in
September 2011 (Juliano 2012). At this programme, par-
ticipants selected from all over Africa were trained in
how best to teach neuroscience concepts using simple-
but-effective approaches (Juliano 2012). In addition, The
International Parkinson and Movement Disorder Society
and the World Federation of Neurology recently teamed
up to organise short training courses for non-neurology
specialist physicians in Ghana and elsewhere in West
Africa (Cilia 2013). The purpose of this initiative was to
help improve the quality of clinical neurology in the sub-con-
tinent, by ensuring that more non-specialists are trained to
become more competent in diagnosing and treating neurology
cases (Cilia 2013). More of such programmes are needed to
help improve the capacity of both scientists and clinicians in
Ghana in neuroscience.
Neuroscience research funding
With the existing challenges involved in accessing govern-
ment funding for research, conducting cutting-edge research
to help tackle local health needs is difficult in Ghana (Karikari
2015a). The country lacks established mechanisms to compet-
itively fund research, innovation and technological develop-
ment (UNCTAD 2011). Notably, the financial contribution of
the Government towards basic research is low; for example,
only about 0.3 % of the country’s gross domestic product is
allocated to basic research (UNCTAD 2011). However, only
about 10% of this fund is used to support actual reseach costs,
since about 90 % is spent on staff remuneration and other
operational costs (UNCTAD 2011). In addition, there is no
government-led competitive research funding programme in
Ghana, meaning that scientists often rely on funding from
international agencies for their research (Karikari 2015a).
However, the research priorities attached to these international
funding calls may not be necessarily aligned with the research
priorities of Ghana (Karikari 2015a; UNCTAD 2011). Also,
the highly-competitive nature of international funding
programmes makes it difficult for early-career scientists and
senior scientists with low publication records to obtain
funding. Concerning funding improvements, the African
Union, about a decade ago, challenged all member states to
spend 1 % of their gross domestic product on local research
and development (Irikefe et al. 2011). However, Ghana has
not been able to reach this research funding target (Irikefe
et al. 2011; UNCTAD 2011). To ensure that more Ghanaian
scientists conduct research that is in line with national research
priorities, more funding support from the Government, indus-
tries, charity organisations and philanthropists will be neces-
sary (Karikari 2015a; Karikari et al. 2015a; Karikari and
Aleksic 2015; Quansah and Karikari 2015; UNCTAD 2011).
Increasing financial investment would not only help to ensure
the long-term sustenance of neuroscience research in Ghana,
but would also help to improve local neurological healthcare.
Mechanisms should also be put in place to ensure that gov-
ernmental funding allocated to higher education institutions
are spent specifically on the indicated assignments.
Conclusion
In this study, we have shown that considerable progress has
been made in neuroscience-related research in Ghana over the
last two decades. Research interest has centred mainly on
hospital and community-based surveys into neurocognitive
impairments in non-nervous system disorders, depression
and suicide, epilepsy and seizures, neurological impact of
substance misuse, and neurological disorders. Importantly,
productivity in neuroscience-related research has increased
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in recent times, with about 60 % of research output over the
last two decades recorded in 2009–2015.
Notwithstanding the progress made, more needs to be done
to improve future research output in this area. Particular areas
that future research should focus on include epidemiology of
neurological and neuropsychiatric disorders, effectiveness of
treatment options, and the genetic, molecular and genomic
basis of these disorders. This might lead to the identification
of disease risk factors as well as genetic factors that either
protect or predispose individuals to specific diseases, with
important implications for clinical intervention and disease
management. Research infrastructural constraints, low
funding issues, and the lack of expert scientists and neurosci-
ence degree programmes are important issues that need to be
addressed to ensure sustainable development of neuroscience
in the country.
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